The study and publication of this infographic were funded by Sanofi.
Nine in 10 people hospitalized with influenza have at least one underlying health condition. This infographic assesses high-dose versus standard-dose influenza vaccine protection against severe outcomes in older adults with chronic conditions.
Drawing on FLUNITY-HD, a prespecified pooled analysis of the DANFLU-2 and GALFLU trials across nearly half a million individually randomized older adults, the infographic examines whether added benefits are consistent across different patient populations. Explore prespecified subgroup analyses of hospitalization for pneumonia or influenza in patients with and without heart failure, diabetes, atrial fibrillation, chronic kidney disease, and chronic lung disease, along with a guide to reading the plot.
